Skip to content
Open access · OA via OpenAlex

Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease

Sofie Bekaert, Tim De Meyer, Ernst Rietzschel, Marc De Buyzere, Dirk De Bacquer, Michel R. Langlois, Patrick Segers, Luc De Cooman, Piet Van Damme, Peter Cassiman, Wim Van Criekinge, Pascal Verdonck, Guy De Backer, Thierry Gillebert, Patrick Van Oostveldt

Aging Cell · 2007 · ▲ 351 citations

Abstract

Evidence assembled over the last decade shows that average telomere(definition) length (TL) acts as a biomarker for biological aging and cardiovascular disease (CVD) in particular. Although essential for a more profound understanding of the underlying mechanisms, little reference information is available on TL. We therefore sought to provide baseline TL information and assess the association of prevalent CVD risk factors with TL in subjects free of overt CVD within a small age range. We measured mean telomere restriction fragment length of peripheral blood leukocytes in a large, representative Asklepios study cohort of 2509 community-dwelling, Caucasian female and male volunteers aged approximately 35-55 years and free of overt CVD. We found a manifest age-dependent telomere attrition, at a significantly faster rate in men as compared to women. No significant associations were established with classical CVD risk factors such as cholesterol status and blood pressure, yet shorter TL was associated with increased levels of several inflammation and oxidative stress markers. Importantly, shorter telomere length was associated with an increasingly unhealthy lifestyle, particularly in men. All findings were age and gender adjusted where appropriate. With these cross-sectional results we show that TL of peripheral blood leukocytes primarily reflects the burden of increased oxidative stress and inflammation, whether or not determined by an increasingly unhealthy lifestyle, while the association with classical CVD risk factors is limited. This further clarifies the added value of TL as a biomarker for biological aging and might improve our understanding of how TL is associated with CVD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/j.1474-9726.2007.00321.x
Canonical
link ↗
Fetched
2026-06-02 MST

Cite this

APA
Bekaert, S., Meyer, T.D., Rietzschel, E., Buyzere, M.D., Bacquer, D.D., Langlois, M.R., Segers, P., Cooman, L.D., Damme, P.V., Cassiman, P., Criekinge, W.V., Verdonck, P., Backer, G.D., Gillebert, T., Oostveldt, P.V., &amp; investigators, O.B.O.T.A. (2007). Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease. <em>Aging Cell</em>. https://doi.org/10.1111/j.1474-9726.2007.00321.x
Vancouver
Bekaert S, Meyer TD, Rietzschel E, Buyzere MD, Bacquer DD, Langlois MR, et al. Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease. Aging Cell. 2007. doi:10.1111/j.1474-9726.2007.00321.x.
BibTeX
@article{sofie2007Telome, title = {Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease}, author = {Sofie Bekaert and Tim De Meyer and Ernst Rietzschel and Marc De Buyzere and Dirk De Bacquer and Michel R. Langlois and Patrick Segers and Luc De Cooman and Piet Van Damme and Peter Cassiman and Wim Van Criekinge and Pascal Verdonck and Guy De Backer and Thierry Gillebert and Patrick Van Oostveldt and on behalf of the Asklepios investigators}, journal = {Aging Cell}, year = {2007}, doi = {10.1111/j.1474-9726.2007.00321.x}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings